Yeji

$LEGN

Legend Biotech Corp

NasdaqMarket cap: —CIK 0001801198

Upcoming catalysts

0 surfaced

No catalysts surfaced for LEGN yet.

Drug pipeline

LUCAR-G79 T cells
Relapsed/Refractory Autoimmune Diseases
LUCAR-DKS1 NK cells
Relapsed/Refractory Autoimmune Diseases
LUCAR-G79D T cells
Systemic Lupus Erythematosus (SLE)
LCAR-B38M CAR-T cell injection
Refractory or Relapsed Multiple Myeloma
LB2102
Small Cell Lung Cancer Extensive Stage
LCAR-AIO T cells
Relapsed/Refractory Autoimmune Diseases
LCAR- F33S cells intravenous infusion
Relapsed/Refractory Multiple Myeloma(MM)
LB1908
Gastric Cancer
LB1901
T-Cell Lymphoma
LCAR-B38M CAR-T Cell
Multiple Myeloma

Recent & active trials

NCTDrugPhaseStatusPrimary completion
NCT07095075LUCAR-DKS1 NK cellsEarly Phase 1Recruiting2029-12-31
NCT07049081LUCAR-G79 T cellsPhase 1Recruiting2028-04-30
NCT07100067LCAR- F33S cells intravenous infusion—Recruiting2028-02-20
NCT07331272LUCAR-G79D T cellsPhase 1Recruiting2028-01-31
NCT05680922LB2102Phase 1Active Not Recruiting2027-12-01
NCT05539430LB1908Phase 1Active Not Recruiting2027-12-01
NCT03758417LCAR-B38M CAR-T CellPhase 2Terminated2025-07-10
NCT06866080LCAR-AIO T cellsEarly Phase 1Withdrawn2025-06-17
NCT03090659LCAR-B38M CAR-T cell injectionPhase 2Unknown2023-12-31
NCT04712864LB1901Phase 1Unknown2023-12-01